FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称QUAVONLIMAB
异名/同义词IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN 4) (HUMAN-MUS MUSCULUS MONOCLONAL M3 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL M3 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)), HUMANIZED MONOCLONAL ANTIBODY
MK-1308A COMPONENT QUAVONLIMAB
QUAVONLIMAB
QUAVONLIMAB [INN]
QUAVONLIMAB [USAN]
QUAVONLIMAB [WHO-DD]
CAS登记号2254059-25-9
物质唯一标识(Unique Ingredient Identifier)GG0AN49Y59
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System